- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06427473
Effectiveness of a Combined Diet and Mindfulness Program on Weight Loss in Breast Cancer Survivors
Effectiveness of a Combined Diet and Mindfulness Program on Weight Loss in Breast Cancer Survivors: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
[Research Background] Breast cancer ranks first among cancers in women worldwide, with overweight and obesity being one of the high-risk factors for breast cancer. Moreover, overweight individuals within the breast cancer patient population also face higher recurrence rates and mortality risks. Assisting overweight or obese breast cancer women in weight loss to promote their well-being was the initial idea behind this study. The most common weight loss strategies include dietary management and regular exercise. In recent years, more studies have shown that effective weight loss also requires psychological interventions. Therefore, this study will combine dietary, exercise, and mindfulness-related interventions to assist breast cancer patients in more effective weight management.
[Research Objectives] To compare the effectiveness of two intervention measures, the Diet, Exercise, and Mindfulness (DEM) model and the Diet and Exercise (DE) model, on weight loss, self-efficacy, mindfulness tendency, and quality of life.
[Research Method] The study will involve a quantitative study, which plans to carry out a randomized controlled trial (RCT). This trial will compare the effects of two intervention measures, the DEM model and the DE model, on weight loss, self-efficacy, mindfulness tendency, and quality of life.
[Expected Results] Through the intervention provided by this study, patients can engage in long-term online self-learning and supplementary learning after returning home, reducing the limitations of ineffective self-management learning caused by negative emotions, treatment side effects, and sequelae in the early stages of cancer. Healthcare professionals can also use scenario-based teaching materials produced by this study to guide breast cancer survivors with ineffective weight self-management skills in practicing the necessary skills. Additionally, through online learning, patients can learn and review without pressure, saving time on transportation, easing carbon foot print and relearning effective weight management skills; even if they have faced major life threats in the past, they can turn adversity into blessings, achieving a balance among physical, mental, and spiritual health.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 112
- National Yang Ming Chiao Tung University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- stage I-III breast cancer and completed treatment
- Body mass index (BMI) is greater than or equal to 24 kg/m2
- possess a smartphone
Exclusion Criteria:
- Pregnant or planning to become pregnant within six months
- Those who are unable to walk
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DEM model
subjects participate diet, exercise and mindfulness programs
|
Participants will attend 8-week online dietary course.
In addition to weekly classes, participants are required to photograph each meal.
Everyday walking steps more than 4000 steps.
To accurately track participants' daily step counts, the research team provided quailfied pedometers.
Participants will attend 8-week online mindfulness course.
In addition to weekly classes, participants practiced mindfulness individually for 5 minutes each day and maintained a mindfulness diary.
|
|
Active Comparator: DE model
subjects participate diet and exercise programs
|
Participants will attend 8-week online dietary course.
In addition to weekly classes, participants are required to photograph each meal.
Everyday walking steps more than 4000 steps.
To accurately track participants' daily step counts, the research team provided quailfied pedometers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physiological indicator I
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
|
BMI in kg/m2 (weight in kilograms divided by height in meters squared)
|
baseline, 8 weeks, 24 weeks, 48 weeks
|
|
Physiological indicator II
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
|
Waist circumference in centimeter
|
baseline, 8 weeks, 24 weeks, 48 weeks
|
|
Physiological indicator III
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
|
Body fat in percentage
|
baseline, 8 weeks, 24 weeks, 48 weeks
|
|
Physiological indicator IV
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
|
Muscle mass in kilograms
|
baseline, 8 weeks, 24 weeks, 48 weeks
|
|
Food Intake Frequency
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
|
Food Frequency Questionnaire
|
baseline, 8 weeks, 24 weeks, 48 weeks
|
|
Mindful Awareness Attention
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
|
The minimum value is 1 and maximum value is 6, and higher scores mean a better outcome.
|
baseline, 8 weeks, 24 weeks, 48 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Efficacy Lifestyle Questionnaire
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
|
The minimum value is 0 and maximum value is 10, and higher scores mean a better outcome.
|
baseline, 8 weeks, 24 weeks, 48 weeks
|
|
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
|
|
baseline, 8 weeks, 24 weeks, 48 weeks
|
|
Breast Cancer-Specific Quality of Life Questionnaire
Time Frame: baseline, 8 weeks, 24 weeks, 48 weeks
|
The minimum value is 1 and maximum value is 4, and lower scores mean a better outcome.
|
baseline, 8 weeks, 24 weeks, 48 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Associate Professor, National Yang Ming Chiao Tung University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NYCU113018AE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
Oncoliq US IncRecruitingBreast Cancer Female | Breast Cancer Detection | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer With Low to Intermediate HER2 Expression | Breast Cancer - Female | Breast Cancer (Early Breast Cancer) | Breast Cancer - Ductal Carcinoma in Situ (DCIS) | Breast Cancer - Infiltrating...Argentina
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Case Comprehensive Cancer CenterNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
Clinical Trials on Dietary program
-
Alberta Hip and Knee ClinicUniversity of CalgaryWithdrawnObesity | Osteo Arthritis Knee | Osteoarthritis, HipCanada
-
Asma YahyaKing Abdullah Medical CityEnrolling by invitationOverweight and ObesitySaudi Arabia
-
Hospital Universitario GetafeCardiff University; Catholic University of the Sacred Heart; University Hospital... and other collaboratorsCompletedType 2 Diabetes MellitusSpain
-
University of RochesterRochester Lifestyle Medicine InstituteCompletedChronic Kidney DiseasesUnited States
-
Mayo ClinicCompleted
-
Habit, LLCUniversity of California, San Diego; TNOCompleted
-
Beth Israel Deaconess Medical CenterYale UniversityCompletedStroke | Obesity | Overweight | HemiparesisUnited States
-
University of South AustraliaFlinders UniversityActive, not recruitingDementia | Alzheimer DiseaseAustralia
-
Universidad de MurciaCompletedPhysical Activity | Frail Elderly Syndrome | AgingSpain
-
University of South CarolinaNational Heart, Lung, and Blood Institute (NHLBI)Completed